Athithi
In a major policy moment, Lilly and Novo Nordisk are in active talks with U.S. officials to cap obesity drug prices, aligning political pressure with market strategy.
CMS’s payment modernization plan seeks to trim inefficiencies, curb wasteful spending in wound care, and realign value in Medicare reimbursement. Providers brace for tighter margins as policymakers hail a new era of cost discipline.
Lepu Medical expands its biotech footprint through a licensing deal with Sidera Bio for MWN105, a triple-agonist drug targeting obesity and metabolic disorders, combining equity, milestone, and royalty gains in a global partnership.
Malaysia’s acceptance of U.S. FDA certificates under the new U.S.–Malaysia reciprocal trade deal.
Funeral reimbursement could transform U.S. organ donation access and equity.
Evernorth’s pricing model overhaul transforms drug access and reimbursement dynamics.
Sprouts files lawsuit over insulin pricing scheme and PBM collusion.
Regeneron boosts its pipeline with multispecific platform for disease innovation.
Thermo Fisher acquisition hits billion mark for Clario.
HAS strengthens stroke management for faster, equitable emergency care access.